{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:40:40Z","timestamp":1783348840881,"version":"3.54.6"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100002848","name":"CONICYT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"FONDECYT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cientifico y Tecnologico","doi-asserted-by":"crossref","award":["N\u00b01140693"],"award-info":[{"award-number":["N\u00b01140693"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["N\u00b0R01HD083323"],"award-info":[{"award-number":["N\u00b0R01HD083323"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Do alterations in pro- and anti-angiogenic estrogen metabolites in follicular fluid (FF) contribute to the follicular growth arrest and anovulation associated with polycystic ovary syndrome (PCOS)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>FF of PCOS women with anovulation have reduced levels of pro-angiogenic estrogen metabolites (EMs) and vascular endothelial growth factor (VEGF) compared to that of fertile women with regular menstrual cycles, but exogenous gonadotropins increase the pro-angiogenic EMs and VEGF levels in PCOS women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>PCOS is characterized by the arrest of follicular development that leads to chronic anovulation. Follicular arrest is generally associated with elevated plasma levels of luteinizing hormone (LH), androgens and anti-Mullerian hormone (AMH). There is also reduced angiogenesis in the follicles of PCOS women compared to those of normal cycling women. It is known that angiogenesis is a critical factor during follicular development. We and other investigators have explored the role of EMs in ovarian angiogenesis, particularly in human corpus luteum function, showing that 4-hydroxyestrone (4-OHE1) and 16-ketoestradiol (16-kE2) have pro-angiogenic effects while 2-methoxyestradiol (2-ME2) and 2-methoxyestrone (2-ME1) have anti-angiogenic effects. Additionally, 2-hydroxyestradiol (2-OHE2), which is produced in the ovary, has proliferative and pro-angiogenic properties. We hypothesized that EMs could be involved in angiogenesis necessary for ovarian follicular development in fertile women, and that dysregulation of these factors may contribute to follicular arrest in PCOS. The relationship between EMs, VEGF and AMH in the pathophysiology of follicular arrest in PCOS has not been previously studied at a follicular level in anovulatory women without ovulation induction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>This is a comparative experimental study of serum and FF collected from different sized follicles (antral \u02c210 mm and dominant \u02c316 mm) of women with and without ovarian stimulation. The study included women with regular menstrual cycles who were proven to be fertile (n\u2009=\u200920) and PCOS women with follicular arrest who were candidates for ovarian drilling (n\u2009=\u200917), as well as other patients requiring ovarian stimulation, i.e. control women undergoing IVF for male factor infertility (n\u2009=\u200912) and PCOS women undergoing IVF (n\u2009=\u200917). In vitro studies were carried out on granulosa-lutein cells (GCs) obtained from subsets of women undergoing IVF for male factor infertility (n\u2009=\u20096) and PCOS women undergoing IVF (n\u2009=\u20096). GCs were maintained in culture for up to 6 days.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Intrafollicular estradiol, estrone and EMs concentrations were determined by high performance liquid chromatography\u2013mass spectrometry. Testosterone in serum was measured by RIA, and LH, FSH and sex hormone-binding globulin in serum were measured with IRMA kits. AMH was determined in serum and FF by enzyme linked immunosorbant assay (ELISA). VEGF levels were measured in FF and conditioned medium by ELISA. Conditioned medium were obtained from cultured GCs. The angiogenic potential was assessed by in vitro angiogenic assays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>Pro-angiogenic EMs (4-OHE1, 16-kE2 and 2-OHE2) and VEGF were lower in FF of antral follicles of PCOS women with follicular arrest compared those of fertile women with ovulatory cycles (P\u2009&amp;lt;\u20090.05). In contrast, higher concentrations of AMH were found in FF of antral follicles from PCOS women with follicular arrest compared to those of fertile women with ovulatory cycles (P\u2009&amp;lt;\u20090.05). Exogenous gonadotropins used in IVF increased pro-angiogenic EMs and VEGF production in PCOS women, reaching similar profiles compared to control women receiving gonadotropins in their IVF treatment for male factor infertility. The pro-angiogenic EM 2-OHE2 increased the angiogenic potential and VEGF levels of GCs from PCOS women compared to the basal condition (P\u2009&amp;lt;\u20090.05). These findings suggest that there is a role for pro-angiogenic EMs in the control of follicular VEGF production.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The limitations include the possibility that in vitro analysis of GCs might not reflect the in vivo mechanisms involved in the pro-angiogenic action of 2-OHE2 since GCs obtained at the time of oocyte retrieval belong to a very early stage of the luteal phase and might not be representative of GCs during follicular growth. Therefore, our findings do not conclusively rule out the possibility that other in vivo mechanisms also account for defective angiogenesis observed in PCOS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>The present study highlights the significance of EMs, angiogenic factors and AMH and their interaction in the pathophysiology of follicular development in PCOS. This study provides new insights into the role of pro-angiogenic factors in follicular arrest in PCOS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This study was funded by CONICYT\/FONDECYT 1140693 and NIH grant R01HD083323. All authors declare no conflict of interest.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deaa098","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T19:10:35Z","timestamp":1587496235000},"page":"1655-1665","source":"Crossref","is-referenced-by-count":31,"title":["Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome"],"prefix":"10.1093","volume":"35","author":[{"given":"Soledad","family":"Henr\u00edquez","sequence":"first","affiliation":[{"name":"Institute for Maternal and Child Research (IDIMI), Faculty of Medicine, University of Chile, Santiago, Chile"},{"name":"Institute of Interdisciplinary Research in Biomedical Sciences (I3CBSEK), Faculty of Health Sciences, SEK University, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Kohen","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Research (IDIMI), Faculty of Medicine, University of Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[{"name":"Research Technology Program, Biomedical Research (formerly SAIC-Frederick), Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Villarroel","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Research (IDIMI), Faculty of Medicine, University of Chile, Santiago, Chile"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, San Borja-Arriaran Clinical Hospital, University of Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Research (IDIMI), Faculty of Medicine, University of Chile, Santiago, Chile"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, San Borja-Arriaran Clinical Hospital, University of Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Godoy","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Research (IDIMI), Faculty of Medicine, University of Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Jerome F","family":"Strauss","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Devoto","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Research (IDIMI), Faculty of Medicine, University of Chile, Santiago, Chile"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, San Borja-Arriaran Clinical Hospital, University of Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"2020071809164353600_deaa098-B1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4067\/S0716-97602009000300012","article-title":"A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line","volume":"42","author":"Aranda","year":"2009","journal-title":"Biol Res"},{"key":"2020071809164353600_deaa098-B2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071809164353600_deaa098-B3","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2020071809164353600_deaa098-B4","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071809164353600_deaa098-B5","first-page":"131","article-title":"Incidence of elevated LH\/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia","volume":"48","author":"Banaszewska","year":"2003","journal-title":"Rocz Akad Med Bialymst"},{"key":"2020071809164353600_deaa098-B6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2008.08.002","article-title":"Anti-M\u00fcllerian hormone and ovarian dysfunction","volume":"19","author":"Broekmans","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2020071809164353600_deaa098-B7","first-page":"1","article-title":"Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility","volume":"1","author":"Costello","year":"2019","journal-title":"Hum Reprod Open"},{"key":"2020071809164353600_deaa098-B8","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/den185","article-title":"AMH is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome","volume":"23","author":"Das","year":"2008","journal-title":"Hum Reprod"},{"key":"2020071809164353600_deaa098-B9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.steroids.2017.05.002","article-title":"The significance of estradiol metabolites in human corpus luteum physiology","volume":"123","author":"Devoto","year":"2017","journal-title":"Steroids"},{"key":"2020071809164353600_deaa098-B1010780","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.fertnstert.2008.04.047","volume":"92","author":"Dumesic","year":"2009","journal-title":"Fertil Steril"},{"key":"2020071809164353600_deaa098-B10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/rep.0.1240601","article-title":"Regulation of ovarian function: the role of anti-M\u00fcllerian hormone","volume":"124","author":"Durlinger","year":"2002","journal-title":"Reproduction"},{"key":"2020071809164353600_deaa098-B11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/BF02623694","article-title":"Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926","volume":"26","author":"Edgell","year":"1990","journal-title":"In Vitro Cell Dev Biol"},{"key":"2020071809164353600_deaa098-B12","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.80.12.3734","article-title":"Permanent cell line expressing human factor VIII-related antigen established by hybridization","volume":"80","author":"Edgell","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071809164353600_deaa098-B13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/humrep\/deh873","article-title":"Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"2020071809164353600_deaa098-B14","article-title":"Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001;280:1358-1366.","author":"Ferrara"},{"key":"2020071809164353600_deaa098-B15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S2007-5057(13)72715-7","article-title":"Sample size calculation in education medical research","volume":"2","author":"Garc\u00eda-Garc\u00eda","year":"2013","journal-title":"Inv Ed Med"},{"key":"2020071809164353600_deaa098-B16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1477-7827-9-116","article-title":"The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"2020071809164353600_deaa098-B17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.rbmo.2017.06.011","article-title":"In-vitro study of gonadotrophin signaling pathways in human granulosa cells in relation to progesterone receptor expression","volume":"35","author":"Henr\u00edquez","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2020071809164353600_deaa098-B18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2016.03.003","article-title":"Estrogen metabolites in human corpus luteum physiology: differential effects on angiogenic activity","volume":"106","author":"Henr\u00edquez","year":"2016","journal-title":"Fertil Steril"},{"key":"2020071809164353600_deaa098-B19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mce.2011.11.022","article-title":"Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome","volume":"350","author":"Hill","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2020071809164353600_deaa098-B20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0303-7207(94)90278-X","article-title":"Follicular oestrogen synthesis: the \u2018two-cell, two-gonadotrophin\u2019 model revisited","volume":"100","author":"Hillier","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"2020071809164353600_deaa098-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.10382.1","article-title":"The novel POSEIDON stratification of \u2018Low prognosis patients in Assisted Reproductive Technology\u2019 and its proposed marker of successful outcome","volume":"5","author":"Humaidan","year":"2016","journal-title":"F1000Res"},{"key":"2020071809164353600_deaa098-B22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1757-2215-7-46","article-title":"Long-term treatment with dehydroepiandrosterone may lead to follicular atresia through interaction with anti-Mullerian hormone","volume":"7","author":"Ikeda","year":"2014","journal-title":"J Ovarian Res"},{"key":"2020071809164353600_deaa098-B23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/cen.13269","article-title":"Anti-M\u00fcllerian hormone reflects the severity of polycystic ovary syndrome","volume":"86","author":"Jacob","year":"2017","journal-title":"Clin Endocrinol (Oxf"},{"key":"2020071809164353600_deaa098-B24","first-page":"157","article-title":"Expression of vascular permeability factor\/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development","volume":"146","author":"Kamat","year":"1995","journal-title":"Am J Pathol"},{"key":"2020071809164353600_deaa098-B25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.fertnstert.2013.07.1980","article-title":"2-Methoxyestradiol in the human corpus luteum throughout the luteal phase and its influence on lutein cell steroidogenesis and angiogenic activity","volume":"100","author":"Kohen","year":"2013","journal-title":"Fertil Steril"},{"key":"2020071809164353600_deaa098-B26","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/jcp.22491","article-title":"Potential role of follicle-stimulating hormone (FSH) and transforming growth factor (TGF\u03b21) in the regulation of ovarian angiogenesis","volume":"226","author":"Kuo","year":"2011","journal-title":"J Cell Physiol"},{"key":"2020071809164353600_deaa098-B27","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1113\/JP274119","article-title":"Convergent ERK1\/2, p38 and JNK mitogen activated protein kinases (MAPKs) signalling mediate catecholoestradiol-induced proliferation of ovine uterine artery endothelial cells","volume":"595","author":"Landeros","year":"2017","journal-title":"J Physiol"},{"key":"2020071809164353600_deaa098-B28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071809164353600_deaa098-B29","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1210\/endo.138.6.5164","article-title":"Preantral ovarian follicles in serum-free culture: suppression of apoptosis after activation of the cyclic guanosine 3\u2019,5\u2019-monophosphate pathway and stimulation of growth and differentiation by follicle-stimulating hormone","volume":"138","author":"McGee","year":"1997","journal-title":"Endocrinology"},{"key":"2020071809164353600_deaa098-B30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/REP-07-0119","article-title":"Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition","volume":"134","author":"Nilsson","year":"2007","journal-title":"Reproduction"},{"key":"2020071809164353600_deaa098-B31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071809164353600_deaa098-B32","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071809164353600_deaa098-B33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1530\/REP-09-0283","article-title":"Angiogenesis and vascular function in the ovary","volume":"138","author":"Robinso","year":"2009","journal-title":"Reproduction"},{"key":"2020071809164353600_deaa098-B34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/rep.0.1220215","article-title":"Intraovarian actions of oestrogen","volume":"122","author":"Rosenfeld","year":"2001","journal-title":"Reproduction"},{"key":"2020071809164353600_deaa098-B35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071809164353600_deaa098-B36","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1210\/jc.2006-2719","article-title":"Lower levels of urinary 2-hydroxyestrogens in polycystic ovary syndrome","volume":"92","author":"Salih","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071809164353600_deaa098-B37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/jc.2013-3186","article-title":"Signaling through FSH receptors on human umbilical vein endothelial cells promotes angiogenesis","volume":"99","author":"Stilley","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071809164353600_deaa098-B5045005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09513590.2017.1381838","article-title":"Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women","author":"Stracquadanio","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"2020071809164353600_deaa098-B38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1439-0531.2004.00505.x","article-title":"Angiogenesis in developing follicle and corpus luteum","volume":"39","author":"Tamanini","year":"2004","journal-title":"Reprod Domest Anim"},{"key":"2020071809164353600_deaa098-B39","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/humrep\/dep113","article-title":"Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome","volume":"24","author":"Valkenburg","year":"2009","journal-title":"Hum Reprod"},{"key":"2020071809164353600_deaa098-B40","first-page":"2S30","article-title":"Role of anti-M\u00fcllerian hormone in follicle recruitment and maturation","volume":"35","author":"Visser","year":"2006","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"2020071809164353600_deaa098-B41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2004.09.008","article-title":"Anti-M\u00fcllerian hormone and folliculogenesis","volume":"234","author":"Visser","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"2020071809164353600_deaa098-B42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"2020071809164353600_deaa098-B43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"2020071809164353600_deaa098-B44","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1210\/endo.143.7.8886","article-title":"Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2","volume":"143","author":"Wulff","year":"2002","journal-title":"Endocrinology"},{"key":"2020071809164353600_deaa098-B45","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1021\/ac070494j","article-title":"Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry","volume":"79","author":"Xu","year":"2007","journal-title":"Anal Chem"},{"key":"2020071809164353600_deaa098-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/carcin\/19.1.1","article-title":"Functional role of estrogen metabolism in target cells: review and perspectives","volume":"19","author":"Zhu","year":"1998","journal-title":"Carcinogenesis"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/7\/1655\/33511416\/deaa098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/7\/1655\/33511416\/deaa098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T13:17:30Z","timestamp":1595078250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/7\/1655\/5859934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,6,19]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa098","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,6,19]]}}}